Philip Mudd

Medicine & Life Sciences

1. SARS Virus 100%
2. Coronavirus 92%
3. T-Lymphocytes 81%
4. Simian Immunodeficiency Virus 49%
5. Human Influenza 38%
6. Infections 38%
7. Severe Acute Respiratory Syndrome 36%
8. Vaccination 34%
9. Vaccines 32%
10. Yellow Fever Vaccine 28%
11. B-Lymphocytes 26%
12. HIV 25%
13. Viruses 24%
14. Cytokines 21%
15. Virus Replication 21%
16. Synthetic Vaccines 20%
17. Epitopes 20%
18. Germinal Center 19%
19. Antibodies 19%
20. Pandemics 19%
21. Neuraminidase 18%
22. Coronavirus Infections 18%
23. Bronchoalveolar Lavage 18%
24. Monocytes 16%
25. Proteomics 16%
26. T-Lymphocyte Epitopes 16%
27. Virus Diseases 15%
28. Catalytic Domain 15%
29. Influenza B virus 14%
30. Hospital Emergency Service 13%
31. Immunity 12%
32. Lymph Nodes 12%
33. Attenuated Vaccines 12%
34. Yellow fever virus 12%
35. Autoantigens 12%
36. Interleukin-6 12%
37. Pulmonary Surfactant-Associated Protein D 12%
38. Messenger RNA 11%
39. Yellow Fever 11%
40. Primary Immunodeficiency Diseases 11%
41. Virus Shedding 11%
42. Reading Frames 10%
43. Interleukin-6 Receptors 10%
44. Helper-Inducer T-Lymphocytes 10%
45. Angioedema 10%
46. Metabolomics 10%
47. Communicable Diseases 10%
48. Cell-Free Nucleic Acids 10%
49. DNA Fingerprinting 10%
50. Healthy Aging 10%